PROM1 and telomere syndrome: Except for BMI1, which has been reported to be highly expressed in fractions of CD133+ SS cells, characterized by increased clonogenicity, self-renewal, and in vivo tumor formation (137), no association between histone modifications and CSC phenotype has been demonstrated to date in STS.